{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,28]],"date-time":"2026-05-28T19:26:59Z","timestamp":1779996419585,"version":"3.53.1"},"reference-count":54,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2014,7,15]],"date-time":"2014-07-15T00:00:00Z","timestamp":1405382400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Hematol Oncol"],"published-print":{"date-parts":[[2014,12]]},"DOI":"10.1186\/s13045-014-0051-y","type":"journal-article","created":{"date-parts":[[2014,7,14]],"date-time":"2014-07-14T15:11:12Z","timestamp":1405350672000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":21,"title":["Low expression of T-cell transcription factor BCL11b predicts inferior survival in adult standard risk T-cell acute lymphoblastic leukemia patients"],"prefix":"10.1186","volume":"7","author":[{"given":"Isabelle","family":"Bartram","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicola","family":"G\u00f6kbuget","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cornelia","family":"Schlee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandra","family":"Heesch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lars","family":"Fransecky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefan","family":"Schwartz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reingard","family":"Stuhlmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kerstin","family":"Sch\u00e4fer-Eckhart","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Starck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Albrecht","family":"Reichle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dieter","family":"Hoelzer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudia D","family":"Baldus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Neumann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2014,7,15]]},"reference":[{"key":"51_CR1","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1053\/j.seminhematol.2008.09.003","volume":"46","author":"N Gokbuget","year":"2009","unstructured":"Gokbuget N, Hoelzer D: Treatment of adult acute lymphoblastic leukemia. Semin Hematol. 2009, 46: 64-75. 10.1053\/j.seminhematol.2008.09.003.","journal-title":"Semin Hematol"},{"key":"51_CR2","doi-asserted-by":"publisher","first-page":"3028","DOI":"10.1182\/blood-2003-10-3560","volume":"104","author":"M Hunault","year":"2004","unstructured":"Hunault M, Harousseau JL, Delain M, Truchan-Graczyk M, Cahn JY, Witz F, Lamy T, Pignon B, Jouet JP, Garidi R, Caillot D, Berthou C, Guyotat D, Sadoun A, Sotto JJ, Lioure B, Casassus P, Solal-Celigny P, Stalnikiewicz L, Audhuy B, Blanchet O, Baranger L, B\u00e9n\u00e9 MC, Ifrah N: Better outcome of adult acute lymphoblastic leukemia after early genoidentical allogeneic bone marrow transplantation (BMT) than after late high-dose therapy and autologous BMT: a GOELAMS trial. Blood. 2004, 104: 3028-3037. 10.1182\/blood-2003-10-3560.","journal-title":"Blood"},{"key":"51_CR3","doi-asserted-by":"publisher","first-page":"532","DOI":"10.1200\/JCO.2010.30.1382","volume":"29","author":"R Bassan","year":"2011","unstructured":"Bassan R, Hoelzer D: Modern therapy of acute lymphoblastic leukemia. J Clin Oncol. 2011, 29: 532-543. 10.1200\/JCO.2010.30.1382.","journal-title":"J Clin Oncol"},{"key":"51_CR4","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1182\/asheducation-2011.1.243","volume":"2011","author":"D Hoelzer","year":"2011","unstructured":"Hoelzer D: Novel antibody-based therapies for acute lymphoblastic leukemia. Hematol Am Soc Hematol Educ Progr. 2011, 2011: 243-249. 10.1182\/asheducation-2011.1.243.","journal-title":"Hematol Am Soc Hematol Educ Progr"},{"key":"51_CR5","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1007\/s11899-013-0160-7","volume":"8","author":"N Daver","year":"2013","unstructured":"Daver N, O'Brien S: Novel therapeutic strategies in adult acute lymphoblastic leukemia - a focus on emerging monoclonal antibodies. Curr Hematol Malig Rep. 2013, 8: 123-131. 10.1007\/s11899-013-0160-7.","journal-title":"Curr Hematol Malig Rep"},{"key":"51_CR6","doi-asserted-by":"publisher","first-page":"5185","DOI":"10.1182\/blood-2012-07-441030","volume":"120","author":"MS Topp","year":"2012","unstructured":"Topp MS, Gokbuget N, Zugmaier G, Degenhard E, Goebeler ME, Klinger M, Neumann SA, Horst HA, Raff T, Viardot A, Stelljes M, Schaich M, K\u00f6hne-Volland R, Br\u00fcggemann M, Ottmann OG, Burmeister T, Baeuerle PA, Nagorsen D, Schmidt M, Einsele H, Riethm\u00fcller G, Kneba M, Hoelzer D, Kufer P, Bargou RC: Long-term follow-up of hematologic relapse-free survival in a phase 2 study of blinatumomab in patients with MRD in B-lineage ALL. Blood. 2012, 120: 5185-5187. 10.1182\/blood-2012-07-441030.","journal-title":"Blood"},{"key":"51_CR7","doi-asserted-by":"publisher","first-page":"3376","DOI":"10.1200\/JCO.2005.03.426","volume":"23","author":"SL Berg","year":"2005","unstructured":"Berg SL, Blaney SM, Devidas M, Lampkin TA, Murgo A, Bernstein M, Billett A, Kurtzberg J, Reaman G, Gaynon P, Whitlock J, Krailo M, Harris MB: Phase II study of nelarabine (compound 506U78) in children and young adults with refractory T-cell malignancies: a report from the children\u2019s oncology group. J Clin Oncol. 2005, 23: 3376-3382. 10.1200\/JCO.2005.03.426.","journal-title":"J Clin Oncol"},{"key":"51_CR8","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1517\/13543784.2011.554822","volume":"20","author":"T Robak","year":"2011","unstructured":"Robak T: New nucleoside analogs for patients with hematological malignancies. Expert Opin Investig Drugs. 2011, 20: 343-359. 10.1517\/13543784.2011.554822.","journal-title":"Expert Opin Investig Drugs"},{"issue":"Suppl 3","key":"51_CR9","doi-asserted-by":"publisher","first-page":"S205","DOI":"10.3816\/CLM.2009.s.013","volume":"9","author":"T Palomero","year":"2009","unstructured":"Palomero T, Ferrando A: Therapeutic targeting of NOTCH1 signaling in T-cell acute lymphoblastic leukemia. Clin Lymphoma Myeloma. 2009, 9 (Suppl 3): S205-S210. 10.3816\/CLM.2009.s.013.","journal-title":"Clin Lymphoma Myeloma"},{"key":"51_CR10","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1016\/S1470-2045(08)70314-0","volume":"10","author":"E Coustan-Smith","year":"2009","unstructured":"Coustan-Smith E, Mullighan CG, Onciu M, Behm FG, Raimondi SC, Pei D, Cheng C, Su X, Rubnitz JE, Basso G, Biondi A, Pui CH, Downing JR, Campana D: Early T-cell precursor leukaemia: a subtype of very high-risk acute lymphoblastic leukaemia. Lancet Oncol. 2009, 10: 147-156. 10.1016\/S1470-2045(08)70314-0.","journal-title":"Lancet Oncol"},{"key":"51_CR11","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1016\/j.beha.2010.08.002","volume":"23","author":"JP Meijerink","year":"2010","unstructured":"Meijerink JP: Genetic rearrangements in relation to immunophenotype and outcome in T-cell acute lymphoblastic leukaemia. Best Pract Res Clin Haematol. 2010, 23: 307-318. 10.1016\/j.beha.2010.08.002.","journal-title":"Best Pract Res Clin Haematol"},{"key":"51_CR12","doi-asserted-by":"crossref","unstructured":"Neumann M, Heesch S, Gokbuget N, Schwartz S, Schlee C, Benlasfer O, Farhadi-Sartangi N, Thibaut J, Burmeister T, Hoelzer D, Hofmann WK, Thiel E, Baldus CD: Clinical and molecular characterization of early T-cell precursor leukemia: a high-risk subgroup in adult T-ALL with a high frequency of FLT3 mutations.Blood Cancer J 2012, 2:e55.","DOI":"10.1038\/bcj.2011.49"},{"key":"51_CR13","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1111\/j.1600-065X.2010.00953.x","volume":"238","author":"P Liu","year":"2010","unstructured":"Liu P, Li P, Burke S: Critical roles of Bcl11b in T-cell development and maintenance of T-cell identity. Immunol Rev. 2010, 238: 138-149. 10.1111\/j.1600-065X.2010.00953.x.","journal-title":"Immunol Rev"},{"key":"51_CR14","doi-asserted-by":"publisher","first-page":"72","DOI":"10.2183\/pjab.88.72","volume":"88","author":"R Kominami","year":"2012","unstructured":"Kominami R: Role of the transcription factor Bcl11b in development and lymphomagenesis. Proc Jpn Acad Ser B Phys Biol Sci. 2012, 88: 72-87. 10.2183\/pjab.88.72.","journal-title":"Proc Jpn Acad Ser B Phys Biol Sci"},{"key":"51_CR15","doi-asserted-by":"publisher","first-page":"3380","DOI":"10.1038\/onc.2009.193","volume":"28","author":"T Cherrier","year":"2009","unstructured":"Cherrier T, Suzanne S, Redel L, Calao M, Marban C, Samah B, Mukerjee R, Schwartz C, Gras G, Sawaya BE, Zeichner SL, Aunis D, Van Lint C, Rohr O: p21(WAF1) gene promoter is epigenetically silenced by CTIP2 and SUV39H1. Oncogene. 2009, 28: 3380-3389. 10.1038\/onc.2009.193.","journal-title":"Oncogene"},{"key":"51_CR16","doi-asserted-by":"publisher","first-page":"2695","DOI":"10.1182\/blood-2006-05-021790","volume":"108","author":"VB Cismasiu","year":"2006","unstructured":"Cismasiu VB, Ghanta S, Duque J, Albu DI, Chen HM, Kasturi R, Avram D: BCL11B participates in the activation of IL2 gene expression in CD4+ T lymphocytes. Blood. 2006, 108: 2695-2702. 10.1182\/blood-2006-05-021790.","journal-title":"Blood"},{"key":"51_CR17","doi-asserted-by":"publisher","first-page":"32272","DOI":"10.1074\/jbc.M602776200","volume":"281","author":"A Topark-Ngarm","year":"2006","unstructured":"Topark-Ngarm A, Golonzhka O, Peterson VJ, Barrett B, Martinez B, Crofoot K, Filtz TM, Leid M: CTIP2 associates with the NuRD complex on the promoter of p57KIP2, a newly identified CTIP2 target gene. J Biol Chem. 2006, 281: 32272-32283. 10.1074\/jbc.M602776200.","journal-title":"J Biol Chem"},{"key":"51_CR18","doi-asserted-by":"publisher","first-page":"3797","DOI":"10.1038\/sj.onc.1210152","volume":"26","author":"P Grabarczyk","year":"2007","unstructured":"Grabarczyk P, Przybylski GK, Depke M, Volker U, Bahr J, Assmus K, Broker BM, Walther R, Schmidt CA: Inhibition of BCL11B expression leads to apoptosis of malignant but not normal mature T cells. Oncogene. 2007, 26: 3797-3810. 10.1038\/sj.onc.1210152.","journal-title":"Oncogene"},{"key":"51_CR19","doi-asserted-by":"publisher","first-page":"3799","DOI":"10.1021\/pr901096u","volume":"9","author":"NK Karanam","year":"2010","unstructured":"Karanam NK, Grabarczyk P, Hammer E, Scharf C, Venz S, Gesell-Salazar M, Barthlen W, Przybylski GK, Schmidt CA, Volker U: Proteome analysis reveals new mechanisms of Bcl11b-loss driven apoptosis. J Proteome Res. 2010, 9: 3799-3811. 10.1021\/pr901096u.","journal-title":"J Proteome Res"},{"key":"51_CR20","doi-asserted-by":"crossref","unstructured":"Grabarczyk P, Nahse V, Delin M, Przybylski G, Depke M, Hildebrandt P, Volker U, Schmidt CA: Increased expression of bcl11b leads to chemoresistance accompanied by G1 accumulation.PLoS One 2010, 5:e12532.","DOI":"10.1371\/journal.pone.0012532"},{"key":"51_CR21","doi-asserted-by":"publisher","first-page":"598","DOI":"10.1016\/S0006-291X(02)03069-3","volume":"301","author":"Y Wakabayashi","year":"2003","unstructured":"Wakabayashi Y, Inoue J, Takahashi Y, Matsuki A, Kosugi-Okano H, Shinbo T, Mishima Y, Niwa O, Kominami R: Homozygous deletions and point mutations of the Rit1\/Bcl11b gene in gamma-ray induced mouse thymic lymphomas. Biochem Biophys Res Commun. 2003, 301: 598-603. 10.1016\/S0006-291X(02)03069-3.","journal-title":"Biochem Biophys Res Commun"},{"key":"51_CR22","doi-asserted-by":"publisher","first-page":"538","DOI":"10.1016\/j.bbrc.2007.02.003","volume":"355","author":"K Kamimura","year":"2007","unstructured":"Kamimura K, Ohi H, Kubota T, Okazuka K, Yoshikai Y, Wakabayashi Y, Aoyagi Y, Mishima Y, Kominami R: Haploinsufficiency of Bcl11b for suppression of lymphomagenesis and thymocyte development. Biochem Biophys Res Commun. 2007, 355: 538-542. 10.1016\/j.bbrc.2007.02.003.","journal-title":"Biochem Biophys Res Commun"},{"key":"51_CR23","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1002\/gcc.10194","volume":"37","author":"RA MacLeod","year":"2003","unstructured":"MacLeod RA, Nagel S, Kaufmann M, Janssen JW, Drexler HG: Activation of HOX11L2 by juxtaposition with 3\u2032-BCL11B in an acute lymphoblastic leukemia cell line (HPB-ALL) with t(5;14)(q35;q32.2). Genes Chromosomes Cancer. 2003, 37: 84-91. 10.1002\/gcc.10194.","journal-title":"Genes Chromosomes Cancer"},{"key":"51_CR24","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1038\/sj.leu.2403619","volume":"19","author":"GK Przybylski","year":"2005","unstructured":"Przybylski GK, Dik WA, Wanzeck J, Grabarczyk P, Majunke S, Martin-Subero JI, Siebert R, Dolken G, Ludwig WD, Verhaaf B, van Dongen JJ, Schmidt CA, Langerak AW: Disruption of the BCL11B gene through inv(14)(q11.2q32.31) results in the expression of BCL11B-TRDC fusion transcripts and is associated with the absence of wild-type BCL11B transcripts in T-ALL. Leukemia. 2005, 19: 201-208. 10.1038\/sj.leu.2403619.","journal-title":"Leukemia"},{"key":"51_CR25","doi-asserted-by":"publisher","first-page":"3413","DOI":"10.1182\/blood.V98.12.3413","volume":"98","author":"E Satterwhite","year":"2001","unstructured":"Satterwhite E, Sonoki T, Willis TG, Harder L, Nowak R, Arriola EL, Liu H, Price HP, Gesk S, Steinemann D, Schlegelberger B, Oscier DG, Siebert R, Tucker PW, Dyer MJ: The BCL11 gene family: involvement of BCL11A in lymphoid malignancies. Blood. 2001, 98: 3413-3420. 10.1182\/blood.V98.12.3413.","journal-title":"Blood"},{"key":"51_CR26","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1016\/S0165-4608(03)00302-9","volume":"149","author":"V Bezrookove","year":"2004","unstructured":"Bezrookove V, van Zelderen-Bhola SL, Brink A, Szuhai K, Raap AK, Barge R, Beverstock GC, Rosenberg C: A novel t(6;14)(q25-q27;q32) in acute myelocytic leukemia involves the BCL11B gene. Cancer Genet Cytogenet. 2004, 149: 72-76. 10.1016\/S0165-4608(03)00302-9.","journal-title":"Cancer Genet Cytogenet"},{"key":"51_CR27","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1002\/pbc.22850","volume":"56","author":"JL Oliveira","year":"2011","unstructured":"Oliveira JL, Kumar R, Khan SP, Law ME, Erickson-Johnson M, Oliveira AM, Ketterling RP, Dogan A: Successful treatment of a child with T\/myeloid acute bilineal leukemia associated with TLX3\/BCL11B fusion and 9q deletion. Pediatr Blood Cancer. 2011, 56: 467-469. 10.1002\/pbc.22850.","journal-title":"Pediatr Blood Cancer"},{"key":"51_CR28","doi-asserted-by":"publisher","first-page":"848","DOI":"10.3324\/haematol.2013.095604","volume":"99","author":"S Abbas","year":"2014","unstructured":"Abbas S, Sanders M, Zeilemaker A, Geertsma-Kleinekoort WM, Koenders JE, Kavelaars FG, Abbas ZG, Mahamoud S, Chu IW, Hoogenboezem R, Peeters JK, van Drunen E, van Galen J, Beverloo HB, L\u00f6wenberg B, Valk PJ: Integrated genome-wide genotyping and gene expression profiling reveals BCL11B as a putative oncogene in acute myeloid leukemia with 14q32 aberrations. Haematologica. 2014, 99: 848-57. 10.3324\/haematol.2013.095604.","journal-title":"Haematologica"},{"key":"51_CR29","doi-asserted-by":"publisher","first-page":"1321","DOI":"10.1038\/nm.2246","volume":"16","author":"K De Keersmaecker","year":"2010","unstructured":"De Keersmaecker K, Real PJ, Gatta GD, Palomero T, Sulis ML, Tosello V, Van VP, Barnes K, Castillo M, Sole X, Hadler M, Lenz J, Aplan PD, Kelliher M, Kee BL, Pandolfi PP, Kappes D, Gounari F, Petrie H, Van der Meulen J, Speleman F, Paietta E, Racevskis J, Wiernik PH, Rowe JM, Soulier J, Avran D, Cav\u00e9 H, Dastugue N, Raimondi S: The TLX1 oncogene drives aneuploidy in T cell transformation. Nat Med. 2010, 16: 1321-1327. 10.1038\/nm.2246.","journal-title":"Nat Med"},{"key":"51_CR30","doi-asserted-by":"publisher","first-page":"4169","DOI":"10.1182\/blood-2010-11-318873","volume":"118","author":"A Gutierrez","year":"2011","unstructured":"Gutierrez A, Kentsis A, Sanda T, Holmfeldt L, Chen SC, Zhang J, Protopopov A, Chin L, Dahlberg SE, Neuberg DS, Silverman LB, Winter SS, Hunger SP, Sallan SE, Zha S, Alt FW, Downing JR, Mullighan CG, Look AT: The BCL11B tumor suppressor is mutated across the major molecular subtypes of T-cell acute lymphoblastic leukemia. Blood. 2011, 118: 4169-4173. 10.1182\/blood-2010-11-318873.","journal-title":"Blood"},{"key":"51_CR31","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1038\/ng.2508","volume":"45","author":"K De Keersmaecker","year":"2013","unstructured":"De Keersmaecker K, Atak ZK, Li N, Vicente C, Patchett S, Girardi T, Gianfelici V, Geerdens E, Clappier E, Porcu M, Lahortiga I, Luc\u00e0 R, Yan J, Hulselmans G, Vranckx H, Vandepoel R, Sweron B, Jacobs K, Mentens N, Wlodarska I, Cauwelier B, Cloos J, Soulier J, Uyttebroeck A, Bagni C, Hassan BA, Vandenberghe P, Johnson AW, Aerts S, Cools J: Exome sequencing identifies mutation in CNOT3 and ribosomal genes RPL5 and RPL10 in T-cell acute lymphoblastic leukemia. Nat Genet. 2013, 45: 186-190. 10.1038\/ng.2508.","journal-title":"Nat Genet"},{"key":"51_CR32","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1182\/blood-2013-03-491092","volume":"122","author":"P Van Vlierberghe","year":"2013","unstructured":"Van Vlierberghe P, Ambesi-Impiombato A, De Keersmaecker K, Hadler M, Paietta E, Tallman MS, Rowe JM, Forne C, Rue M, Ferrando AA: Prognostic relevance of integrated genetic profiling in adult T-cell acute lymphoblastic leukemia. Blood. 2013, 122: 74-82. 10.1182\/blood-2013-03-491092.","journal-title":"Blood"},{"key":"51_CR33","doi-asserted-by":"publisher","first-page":"2529","DOI":"10.1200\/JCO.2009.23.4732","volume":"28","author":"T Haferlach","year":"2010","unstructured":"Haferlach T, Kohlmann A, Wieczorek L, Basso G, Kronnie GT, Bene MC, De VJ, Hernandez JM, Hofmann WK, Mills KI, Gilkes A, Chiaretti S, Shurtleff SA, Kipps TJ, Rassenti LZ, Yeoh AE, Papenhausen PR, Liu WM, Williams PM, Fo\u00e0 R: Clinical utility of microarray-based gene expression profiling in the diagnosis and subclassification of leukemia: report from the international microarray innovations in leukemia study group. J Clin Oncol. 2010, 28: 2529-2537. 10.1200\/JCO.2009.23.4732.","journal-title":"J Clin Oncol"},{"key":"51_CR34","doi-asserted-by":"publisher","first-page":"3739","DOI":"10.1200\/JCO.2007.11.5253","volume":"25","author":"CD Baldus","year":"2007","unstructured":"Baldus CD, Martus P, Burmeister T, Schwartz S, Gokbuget N, Bloomfield CD, Hoelzer D, Thiel E, Hofmann WK: Low ERG and BAALC expression identifies a new subgroup of adult acute T-lymphoblastic leukemia with a highly favorable outcome. J Clin Oncol. 2007, 25: 3739-3745. 10.1200\/JCO.2007.11.5253.","journal-title":"J Clin Oncol"},{"key":"51_CR35","doi-asserted-by":"publisher","first-page":"1429","DOI":"10.1038\/leu.2010.130","volume":"24","author":"S Heesch","year":"2010","unstructured":"Heesch S, Schlee C, Neumann M, Stroux A, Kuhnl A, Schwartz S, Haferlach T, Goekbuget N, Hoelzer D, Thiel E, Hofmann WK, Baldus CD: BAALC-associated gene expression profiles define IGFBP7 as a novel molecular marker in acute leukemia. Leukemia. 2010, 24: 1429-1436. 10.1038\/leu.2010.130.","journal-title":"Leukemia"},{"key":"51_CR36","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1073\/pnas.91.2.459","volume":"91","author":"D Small","year":"1994","unstructured":"Small D, Levenstein M, Kim E, Carow C, Amin S, Rockwell P, Witte L, Burrow C, Ratajczak MZ, Gewirtz AM, Civin CI: STK-1, the human homolog of Flk-2\/Flt-3, is selectively expressed in CD34+ human bone marrow cells and is involved in the proliferation of early progenitor\/stem cells. Proc Natl Acad Sci U S A. 1994, 91: 459-463. 10.1073\/pnas.91.2.459.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"51_CR37","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1016\/j.cell.2011.01.004","volume":"144","author":"N Novershtern","year":"2011","unstructured":"Novershtern N, Subramanian A, Lawton LN, Mak RH, Haining WN, McConkey ME, Habib N, Yosef N, Chang CY, Shay T, Frampton GM, Drake AC, Leskov I, Nilsson B, Preffer F, Dombkowski D, Evans JW, Liefeld T, Smutko JS, Chen J, Friedman N, Young RA, Golub TR, Regev A, Ebert BL: Densely interconnected transcriptional circuits control cell states in human hematopoiesis. Cell. 2011, 144: 296-309. 10.1016\/j.cell.2011.01.004.","journal-title":"Cell"},{"key":"51_CR38","first-page":"1060","volume":"9","author":"HD Menssen","year":"1995","unstructured":"Menssen HD, Renkl HJ, Rodeck U, Maurer J, Notter M, Schwartz S, Reinhardt R, Thiel E: Presence of Wilms' tumor gene (wt1) transcripts and the WT1 nuclear protein in the majority of human acute leukemias. Leukemia. 1995, 9: 1060-1067.","journal-title":"Leukemia"},{"key":"51_CR39","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1016\/j.coi.2011.12.012","volume":"24","author":"EV Rothenberg","year":"2012","unstructured":"Rothenberg EV: Transcriptional drivers of the T-cell lineage program. Curr Opin Immunol. 2012, 24: 132-138. 10.1016\/j.coi.2011.12.012.","journal-title":"Curr Opin Immunol"},{"key":"51_CR40","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1126\/science.1188989","volume":"329","author":"L Li","year":"2010","unstructured":"Li L, Leid M, Rothenberg EV: An early T cell lineage commitment checkpoint dependent on the transcription factor Bcl11b. Science. 2010, 329: 89-93. 10.1126\/science.1188989.","journal-title":"Science"},{"key":"51_CR41","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1016\/j.it.2011.06.005","volume":"32","author":"U Koch","year":"2011","unstructured":"Koch U, Radtke F: Notch in T-ALL: new players in a complex disease. Trends Immunol. 2011, 32: 434-442. 10.1016\/j.it.2011.06.005.","journal-title":"Trends Immunol"},{"key":"51_CR42","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1126\/science.1102160","volume":"306","author":"AP Weng","year":"2004","unstructured":"Weng AP, Ferrando AA, Lee W, Morris JP, Silverman LB, Sanchez-Irizarry C, Blacklow SC, Look AT, Aster JC: Activating mutations of NOTCH1 in human T cell acute lymphoblastic leukemia. Science. 2004, 306: 269-271. 10.1126\/science.1102160.","journal-title":"Science"},{"key":"51_CR43","doi-asserted-by":"publisher","first-page":"3398","DOI":"10.1172\/JCI61269","volume":"122","author":"VP Van","year":"2012","unstructured":"Van VP, Ferrando A: The molecular basis of T cell acute lymphoblastic leukemia. J Clin Invest. 2012, 122: 3398-3406. 10.1172\/JCI61269.","journal-title":"J Clin Invest"},{"key":"51_CR44","first-page":"933","volume":"7","author":"A Kikuchi","year":"1993","unstructured":"Kikuchi A, Hayashi Y, Kobayashi S, Hanada R, Moriwaki K, Yamamoto K, Fujimoto J, Kaneko Y, Yamamori S: Clinical significance of TAL1 gene alteration in childhood T-cell acute lymphoblastic leukemia and lymphoma. Leukemia. 1993, 7: 933-938.","journal-title":"Leukemia"},{"key":"51_CR45","doi-asserted-by":"publisher","first-page":"2324","DOI":"10.1182\/blood-2007-04-079988","volume":"110","author":"J Bergeron","year":"2007","unstructured":"Bergeron J, Clappier E, Radford I, Buzyn A, Millien C, Soler G, Ballerini P, Thomas X, Soulier J, Dombret H, Macintyre EA, Asnafi V: Prognostic and oncogenic relevance of TLX1\/HOX11 expression level in T-ALLs. Blood. 2007, 110: 2324-2330. 10.1182\/blood-2007-04-079988.","journal-title":"Blood"},{"key":"51_CR46","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/j.bcmd.2012.09.001","volume":"50","author":"MD Kraszewska","year":"2013","unstructured":"Kraszewska MD, Dawidowska M, Kosmalska M, Sedek L, Grzeszczak W, Kowalczyk JR, Szczepanski T, Witt M: BCL11B, FLT3, NOTCH1 and FBXW7 mutation status in T-cell acute lymphoblastic leukemia patients. Blood Cells Mol Dis. 2013, 50: 33-38. 10.1016\/j.bcmd.2012.09.001.","journal-title":"Blood Cells Mol Dis"},{"key":"51_CR47","doi-asserted-by":"crossref","unstructured":"Kurosawa N, Fujimoto R, Ozawa T, Itoyama T, Sadamori N, Isobe M: Reduced level of the BCL11B protein is associated with adult T-cell leukemia\/lymphoma.PLoS One 2013, 8:e55147.","DOI":"10.1371\/journal.pone.0055147"},{"key":"51_CR48","doi-asserted-by":"publisher","first-page":"1116","DOI":"10.1182\/blood-2005-07-2708","volume":"107","author":"M Br\u00fcggemann","year":"2006","unstructured":"Br\u00fcggemann M, Raff T, Flohr T, Gokbuget N, Nakao M, Droese J, Luschen S, Pott C, Ritgen M, Scheuring U, Horst HA, Thiel E, Hoelzer D, Bartram CR, Kneba M: Clinical significance of minimal residual disease quantification in adult patients with standard-risk acute lymphoblastic leukemia. Blood. 2006, 107: 1116-1123. 10.1182\/blood-2005-07-2708.","journal-title":"Blood"},{"key":"51_CR49","doi-asserted-by":"publisher","first-page":"1383","DOI":"10.3324\/haematol.2008.005272","volume":"94","author":"CD Baldus","year":"2009","unstructured":"Baldus CD, Thibaut J, Goekbuget N, Stroux A, Schlee C, Mossner M, Burmeister T, Schwartz S, Bloomfield CD, Hoelzer D, Thiel E, Hofmann WK: Prognostic implications of NOTCH1 and FBXW7 mutations in adult acute T-lymphoblastic leukemia. Haematologica. 2009, 94: 1383-1390. 10.3324\/haematol.2008.005272.","journal-title":"Haematologica"},{"issue":"Suppl 1","key":"51_CR50","first-page":"S129","volume":"83","author":"N Gokbuget","year":"2004","unstructured":"Gokbuget N, Raff R, Br\u00fcggemann M, Flohr T, Scheuring U, Pfeifer H, Bartram CR, Kneba M, Hoelzer D: Risk\/MRD adapted GMALL trials in adult ALL. Ann Hematol. 2004, 83 (Suppl 1): S129-S131.","journal-title":"Ann Hematol"},{"key":"51_CR51","unstructured":"European leukemia Net. European leukemia trial registry trial: ALL GMALL 07\/2003.. Accessed September 3, 2013. ., [http:\/\/www.leukemia-net.org\/trial\/download\/public\/ALL_GMALL07-03_ShortProtEN.pdf?id=489]"},{"key":"51_CR52","doi-asserted-by":"publisher","first-page":"4714","DOI":"10.1200\/JCO.2006.06.1580","volume":"24","author":"CD Baldus","year":"2006","unstructured":"Baldus CD, Burmeister T, Martus P, Schwartz S, Gokbuget N, Bloomfield CD, Hoelzer D, Thiel E, Hofmann WK: High expression of the ETS transcription factor ERG predicts adverse outcome in acute T-lymphoblastic leukemia in adults. J Clin Oncol. 2006, 24: 4714-4720. 10.1200\/JCO.2006.06.1580.","journal-title":"J Clin Oncol"},{"key":"51_CR53","doi-asserted-by":"publisher","first-page":"942","DOI":"10.3324\/haematol.2009.016386","volume":"95","author":"S Heesch","year":"2010","unstructured":"Heesch S, Goekbuget N, Stroux A, Tanchez JO, Schlee C, Burmeister T, Schwartz S, Blau O, Keilholz U, Busse A, Hoelzer D, Thiel E, Hofmann WK, Baldus CD: Prognostic implications of mutations and expression of the Wilms tumor 1 (WT1) gene in adult acute T-lymphoblastic leukemia. Haematologica. 2010, 95: 942-949. 10.3324\/haematol.2009.016386.","journal-title":"Haematologica"},{"key":"51_CR54","doi-asserted-by":"crossref","unstructured":"Neumann M, Coskun E, Fransecky L, Mochmann LH, Bartram I, Sartangi NF, Heesch S, Gokbuget N, Schwartz S, Brandts C, Schlee C, Haas R, D\u00fchrsen U, Griesshammer M, D\u00f6hner H, Ehninger G, Burmeister T, Blau O, Thiel E, Hoelzer D, Hofmann WK, Baldus CD: FLT3 mutations in early T-cell precursor ALL characterize a stem cell like leukemia and imply the clinical use of tyrosine kinase inhibitors.PLoS One 2013, 8:e53190.","DOI":"10.1371\/journal.pone.0053190"}],"container-title":["Journal of Hematology &amp; Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13045-014-0051-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s13045-014-0051-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13045-014-0051-y","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13045-014-0051-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,2]],"date-time":"2021-09-02T04:54:37Z","timestamp":1630558477000},"score":1,"resource":{"primary":{"URL":"https:\/\/jhoonline.biomedcentral.com\/articles\/10.1186\/s13045-014-0051-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,7,15]]},"references-count":54,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2014,12]]}},"alternative-id":["51"],"URL":"https:\/\/doi.org\/10.1186\/s13045-014-0051-y","relation":{},"ISSN":["1756-8722"],"issn-type":[{"value":"1756-8722","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,7,15]]},"assertion":[{"value":"30 April 2014","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 July 2014","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 July 2014","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"51"}}